A comparison of BRCA1 mutation analysis by direct sequencing, SSCP and DHPLC

Human Genetics

Volumn 105, Issue 1-2, 1999, Pages 72-78

  Gross, Eva ^a   Arnold, Norbert ^a   Goette, Julia ^a   Schwarz Boeger, Ulrike ^a   Kiechle, Marion ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; ONSET AGE; OVARY CANCER; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0032764964     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004399900092     Document Type: Article

References (26)

1. Arnold N, Gross E, Schwarz-BoegerU, Pfisterer J, Jonat W, Kiechle M (1999) A fast, cheap and highly sensitive technique for mutation analysis in hereditary breast and ovarian cancer. Hum Mutat (in press)
2. Breast Cancer Information Core (1999) http://www.nhgri.nih.gov/ Intramural_research/Lab_transfer/BIC/
3. Cotton RGH (1993) Current methods of mutation detection. Mutat Res 285:125-144
4. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen F, Shattuck-Eidens D, Godwin AK, Daly M, Sedlacek S, Radford DM, Rommens J, Simmard J, Garber J, Merajver S, Weber BL (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13:123-125
5. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415
6. Fodde R, Losekoot M (1994) Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum Mutat 3:83-94
7. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Rowell SE, King MC (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 8:399-404
8. Ganguly A, Leahy K, Mashall AM, Dhulipala R, Godmilow L, Ganguly T (1997) Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations. Genet Testing 1:85-90
9. Hoogendoorn B, Owen MJ, Oefner PJ, Williams N, Austin J, O'Donovan MC (1999) Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography. Hum Genet 104:89-93
10. Liu W, Smith DI, Rechtzigel KJ, Thibodeau SN, James CD (1998) Denaturing high performance liquid chromatography (DHPLC) used in the detection of germline and somatic mutations. Nucleic Acids Res 26:1396-1400
11. Markoff A, Savov A, Vladimirov V, Bogdanova N, Kremensky I, Ganev V (1997) Optimization of single-strand conformation polymorphism analysis in the presence of polyethylene glycol. Clin Chem 43:30-33
12. Markoff A, Sormbroen H, Bogdanova N, Preisler-Adams S, Ganev V, Dworniczak B, Horst J (1998) Comparison of conformation-sensitive gel electrophoresis and single-strand conformation polymorphism analysis for detection of mutations in the BRCA1 gene using optimized conformation analysis protocols. Eur J Hum Genet 6:145-150
13. Miki Y, Swenson J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu K, Cochran C, Bennett LM, Ding W, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
14. O'Donovan MC, Oefner PJ, Roberts SC, Austin J, Hoogendoorn B, Guy C, Speight G, Upadhyaya M, Sommer SS, McGuffin P (1998) Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 52:44-49
15. Oefner PJ, Underhill PA (1995) Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC). Am J Hum Genet 57 (suppl):A266
16. Oefner PJ, Underhill PA (1998) DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC). Curr Protocols Hum Genet (Suppl) 19:7.10.1-7.10.12
17. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989) Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770
18. Phelan CM, Lancaster TM, Tonin P, et al (1996) Mutation analysis of BRCA2 gene in 49 site-specific breast cancer families. Nat Med 2:1179-1183
19. Ravnik-Glavak M, Glavac D, Dean M (1994) Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum Mol Gen 3:801-807
20. Richter S, Seth A (1998) One step direct detection of recurrent mutations in the breast cancer susceptibility gene BRCA1. Int J Oncol 12:1263-1267
21. Sarkar G, Yoon HS, Sommer SS (1992) Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP. Nucleic Acids Res 20:871-878
22. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT, Lenoir GM (1997) Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer susceptibility genes? Am J Hum Genet 60:486-495
23. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Tend DH, Adey N, Staebell M, et al (1997) BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA 278:1242-1250
24. Underhill PA, Jin L, Lin AA, Mehdi SQ, Jenkins T, Vollrath D, Davis RW, Cavalli-Sforza LL, Oefner PJ (1997) Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography. Genome Res 7: 996-1005
25. Wagner TM, Moslinger RA, Muhr D, Langbauer G, Hirtenlehner K, Concin H, et al (1998) BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics. Int J Cancer 77:354-360
26. Wooster R, Neuhausen SI, Mangion J, Quirk J, Ford D, Collins N, Nguyen K, Tran T, Averill D, et al (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090